Oral contraceptives and breast cancer. A prospective cohort study.

In 1976, information on oral contraceptive (OC) use as well as numerous risk factors for breast cancer was provided by 121,964 married female registered nurses aged 30 to 55 years. Ninety-two percent of women in the cohort completed follow-up questionnaires, and vital records were systematically sea...

ver descrição completa

Detalhes bibliográficos
Main Authors: Lipnick, R, Buring, J, Hennekens, C, Rosner, B, Willett, W, Bain, C, Stampfer, M, Colditz, G, Peto, R, Speizer, F
Formato: Journal article
Idioma:English
Publicado em: 1986
_version_ 1826283446013526016
author Lipnick, R
Buring, J
Hennekens, C
Rosner, B
Willett, W
Bain, C
Stampfer, M
Colditz, G
Peto, R
Speizer, F
author_facet Lipnick, R
Buring, J
Hennekens, C
Rosner, B
Willett, W
Bain, C
Stampfer, M
Colditz, G
Peto, R
Speizer, F
author_sort Lipnick, R
collection OXFORD
description In 1976, information on oral contraceptive (OC) use as well as numerous risk factors for breast cancer was provided by 121,964 married female registered nurses aged 30 to 55 years. Ninety-two percent of women in the cohort completed follow-up questionnaires, and vital records were systematically searched to ascertain deaths among nonrespondents. After four years of follow-up, 592 incident cases of breast cancer were identified. Compared with never users, the age-adjusted relative risk (RR) of breast cancer, regardless of menopausal status, among all women who had ever used OCs was 1.0. Among premenopausal women compared with those who had never used OCs, the RR of breast cancer was 1.5 for current use of OCs in 1976 and 1.0 for past use. Among postmenopausal women, the RR for past use of OCs was 1.0. These estimates were essentially unaltered after controlling for other known risk factors for breast cancer in multiple logistic regression analysis. Furthermore, there was no modification of these effects by family history of breast cancer, age at first use, timing of the first birth, or other breast cancer risk factors. Data on past use of OCs provide substantial reassuring evidence that there is no large excess risk of breast cancer within a few years of cessation of pill use. The observed moderate elevation of breast cancer risk with current use was of borderline statistical significance. However, the observation was based on 29 cases and may reflect the effect of sampling variability, as most other studies have not observed a relationship between current use of OCs and breast cancer in women of this age.
first_indexed 2024-03-07T00:59:01Z
format Journal article
id oxford-uuid:8913c57f-f811-4f80-ab10-2f06d9b22c3c
institution University of Oxford
language English
last_indexed 2024-03-07T00:59:01Z
publishDate 1986
record_format dspace
spelling oxford-uuid:8913c57f-f811-4f80-ab10-2f06d9b22c3c2022-03-26T22:21:57ZOral contraceptives and breast cancer. A prospective cohort study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8913c57f-f811-4f80-ab10-2f06d9b22c3cEnglishSymplectic Elements at Oxford1986Lipnick, RBuring, JHennekens, CRosner, BWillett, WBain, CStampfer, MColditz, GPeto, RSpeizer, FIn 1976, information on oral contraceptive (OC) use as well as numerous risk factors for breast cancer was provided by 121,964 married female registered nurses aged 30 to 55 years. Ninety-two percent of women in the cohort completed follow-up questionnaires, and vital records were systematically searched to ascertain deaths among nonrespondents. After four years of follow-up, 592 incident cases of breast cancer were identified. Compared with never users, the age-adjusted relative risk (RR) of breast cancer, regardless of menopausal status, among all women who had ever used OCs was 1.0. Among premenopausal women compared with those who had never used OCs, the RR of breast cancer was 1.5 for current use of OCs in 1976 and 1.0 for past use. Among postmenopausal women, the RR for past use of OCs was 1.0. These estimates were essentially unaltered after controlling for other known risk factors for breast cancer in multiple logistic regression analysis. Furthermore, there was no modification of these effects by family history of breast cancer, age at first use, timing of the first birth, or other breast cancer risk factors. Data on past use of OCs provide substantial reassuring evidence that there is no large excess risk of breast cancer within a few years of cessation of pill use. The observed moderate elevation of breast cancer risk with current use was of borderline statistical significance. However, the observation was based on 29 cases and may reflect the effect of sampling variability, as most other studies have not observed a relationship between current use of OCs and breast cancer in women of this age.
spellingShingle Lipnick, R
Buring, J
Hennekens, C
Rosner, B
Willett, W
Bain, C
Stampfer, M
Colditz, G
Peto, R
Speizer, F
Oral contraceptives and breast cancer. A prospective cohort study.
title Oral contraceptives and breast cancer. A prospective cohort study.
title_full Oral contraceptives and breast cancer. A prospective cohort study.
title_fullStr Oral contraceptives and breast cancer. A prospective cohort study.
title_full_unstemmed Oral contraceptives and breast cancer. A prospective cohort study.
title_short Oral contraceptives and breast cancer. A prospective cohort study.
title_sort oral contraceptives and breast cancer a prospective cohort study
work_keys_str_mv AT lipnickr oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT buringj oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT hennekensc oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT rosnerb oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT willettw oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT bainc oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT stampferm oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT colditzg oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT petor oralcontraceptivesandbreastcanceraprospectivecohortstudy
AT speizerf oralcontraceptivesandbreastcanceraprospectivecohortstudy